Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2026-08-13 21:00:05 ET · period of report 2026-08-11 · accession 0001193125-26-349960 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-13 21:00 | 2026-08-11 | WVE | Tan Aik Na | Dir | S - Sale | $6.01 | -432 | 25.0K | -2% | -$2,596 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-11 | S | D | 432 | $6.01 | 24,968 | D | — | — | (F1) On August 11, 2026, the reporting person sold 432 shares of common stock solely to cover taxes associated with the vesting of restricted stock units on August 11, 2026. These sales were made pursuant to a previously adopted 10b5-1 Trading Plan. |